ESKD
Showing 26 - 50 of 162
Diabetic Kidney Disease Trial in Herlev (ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide,
Recruiting
- Diabetic Kidney Disease
- ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
-
Herlev, DenmarkDepartment of Nephrology, Herlev and Gentofte Hospital
May 31, 2023
Kinetics of Extracellular Vesicles in Hemodialysis
Not yet recruiting
- End-stage Kidney Disease
- Routine hemodialysis
- (no location specified)
Jul 13, 2023
End-Stage Kidney Disease Trial in Singapore (myKIDNEY decision aid)
Recruiting
- End-Stage Kidney Disease
- myKIDNEY decision aid
-
Singapore, Singapore
- +1 more
Jun 3, 2022
Chronic Kidney Disease Stage 5 on Dialysis Trial in Ferrara (Home-based unstructured physical activity program, Home-based
Recruiting
- Chronic Kidney Disease Stage 5 on Dialysis
- Home-based unstructured physical activity program
- +2 more
-
Ferrara, ItalyUniversity Hospital of Ferrara
Nov 2, 2022
Glomerulonephritis, Immunoglobulin A Nephropathy Trial (Corticosteroid, Renin-angiotensin sytem blockers, Sodium-glucose
Not yet recruiting
- Glomerulonephritis
- Immunoglobulin A Nephropathy
- Corticosteroid
- +2 more
- (no location specified)
Oct 13, 2021
End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)
Not yet recruiting
- End-Stage Kidney Disease
- End-Stage Renal Disease
- Metoprolol Succinate
- Carvedilol
-
Boston, Massachusetts
- +4 more
Jun 26, 2023
SODIUM ACCUMULATION STUDY IN HAEMODIALYSIS: BRAIN STUDY
Not yet recruiting
- Dialysis; Complications
-
Derby, United KingdomCentre for Kidney Research and Innovation
Jul 21, 2023
End Stage Renal Disease, Kidney Failure Trial in New York, Cleveland (Provider educational materials, Patient letters)
Not yet recruiting
- End Stage Renal Disease
- Kidney Failure
- Provider educational materials
- Patient letters
-
New York, New York
- +1 more
Nov 27, 2023
Cardiovascular Diseases, Heart Failure, Type 1 Diabetes Trial (Aspirin tablet, Semaglutide, Sotagliflozin)
Not yet recruiting
- Cardiovascular Diseases
- +3 more
- Aspirin tablet
- +3 more
- (no location specified)
Oct 8, 2023
Kidney Failure, Chronic Trial in Porto Alegre (Inspiratory Muscle Training)
Not yet recruiting
- Kidney Failure, Chronic
- Inspiratory Muscle Training
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clínicas de Porto Alegre
Aug 26, 2021
Heart Failure With Reduced Ejection Fraction Trial (Shengxian Quyu Decoction, Placebo)
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- Shengxian Quyu Decoction
- Placebo
- (no location specified)
Dec 8, 2022
Kidney Failure, Chronic, Hyperphosphatemia Trial in Worldwide (Liberal phosphate target, Intensive phosphate target)
Recruiting
- Kidney Failure, Chronic
- Hyperphosphatemia
- Liberal phosphate target
- Intensive phosphate target
-
Camperdown, New South Wales, Australia
- +70 more
Dec 5, 2022
Focal Segmental Glomerulosclerosis Trial (Metformin + Standard of Care, Placebo + Standard of Care)
Not yet recruiting
- Focal Segmental Glomerulosclerosis
- Metformin + Standard of Care
- Placebo + Standard of Care
- (no location specified)
Oct 13, 2023
Kidney Failure, Chronic Trial in Birmingham (UKidney)
Not yet recruiting
- Kidney Failure, Chronic
- UKidney
-
Birmingham, AlabamaUniversity of Alabama Birmingham
Jan 24, 2023
Chronic Kidney Diseases Trial in Spain (Ambulatory blood pressure monitoring (ABPM), Home blood pressure monitoring (HBPM))
Recruiting
- Chronic Kidney Diseases
- Ambulatory blood pressure monitoring (ABPM)
- Home blood pressure monitoring (HBPM)
-
La Estrada, Pontevedra, Spain
- +7 more
May 16, 2022
Empagliflozin in Type 2 Diabetes Population With and Without
Not yet recruiting
- Diabetes Mellitus, Type 2
- Empagliflozin
- +3 more
-
Durham, North CarolinaDuke Clinical Research Institute
Aug 8, 2022
Kidney Transplant, Type 2 Diabetes Trial in United States (Empagliflozin)
Not yet recruiting
- Kidney Transplant
- Type 2 Diabetes
-
Iowa City, Iowa
- +3 more
Aug 22, 2023
SASH: Sodium Accumulation Study In Haemodialysis
Not yet recruiting
- Haemodialysis
- End Stage Renal Disease on Dialysis
- No intervention will be given in this study
-
Derby, United KingdomUniversity Hospitals of Derby and Burton NHS Foundation Trust
Nov 16, 2021
Diabetes Mellitius Trial (Neutrophil Gelatinase and Kidney Injury Molecule-1)
Not yet recruiting
- Diabetes Mellitius
- Neutrophil Gelatinase and Kidney Injury Molecule-1
- (no location specified)
Sep 4, 2023
End Stage Kidney Disease, Delayed Graft Function, Kidney Transplant; Complications Trial in Australia, New Zealand (Plasma-Lyte
Completed
- End Stage Kidney Disease
- +2 more
- Plasma-Lyte 148 (approx. pH 7.4) IV Infusion
- 0.9% SODIUM CHLORIDE 9g/L injection BP
-
Randwick, New South Wales, Australia
- +17 more
Dec 12, 2022
Phenotyping Seroconversion Following Vaccination Against
Active, not recruiting
- End Stage Kidney Disease
-
Leicester, Leicestershire, United KingdomUniversity Hospital Leicester NHS Trust
May 30, 2022
CKD, Type 2 Diabetes Trial
Not yet recruiting
- CKD
- Type 2 Diabetes
- (no location specified)
Jan 11, 2023
Chronic Kidney Disease With High Proteinuria Trial in Worldwide (Zibotentan/Dapagliflozin, Dapagliflozin)
Not yet recruiting
- Chronic Kidney Disease With High Proteinuria
-
Bakersfield, California
- +99 more
Oct 17, 2023
APOL1 Genetic Testing in African Americans
Recruiting
- Genetic Predisposition
- +2 more
- Assessment of the frequency of APOL-1 renal risk variant in the black population, and evaluating their attitudes about genetic testing and APOL1 genotype via self-administered surveys
-
Saint Louis, MissouriSSM Health Saint Louis University Hospital
Dec 16, 2022
CKD (Chronic Kidney Disease) Stage 5D Trial in China (Aspirin 100 mg Oral Tablet)
Recruiting
- CKD (Chronic Kidney Disease) Stage 5D
- Aspirin 100 mg Oral Tablet
-
Fuzhou, Fujian, China
- +66 more
Jan 6, 2022